Journal article
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer
Abstract
BACKGROUND: Aromatase inhibitors are widely employed in the adjuvant treatment of early stage breast cancer. The impact of aromatase inhibitors has not been established in ethnic minority women.
PATIENTS AND METHODS: The purpose of this study was to evaluate the impact of letrozole on minority women in MA.17, a placebo-controlled trial of letrozole following 5 years of tamoxifen in postmenopausal women with early stage breast cancer. …
Authors
Moy B; Tu D; Pater JL; Ingle JN; Shepherd LE; Whelan TJ; Goss PE
Journal
Annals of Oncology, Vol. 17, No. 11, pp. 1637–1643
Publisher
Elsevier
Publication Date
November 2006
DOI
10.1093/annonc/mdl177
ISSN
0923-7534
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsAromatase InhibitorsBreast NeoplasmsComorbidityDisease-Free SurvivalEthnicityFemaleHumansLetrozoleMental HealthMiddle AgedMinority GroupsNitrilesPainPatient CompliancePostmenopauseTamoxifenTreatment OutcomeTriazolesWhite People